FI903144A0 - MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET. - Google Patents

MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET.

Info

Publication number
FI903144A0
FI903144A0 FI903144A FI903144A FI903144A0 FI 903144 A0 FI903144 A0 FI 903144A0 FI 903144 A FI903144 A FI 903144A FI 903144 A FI903144 A FI 903144A FI 903144 A0 FI903144 A0 FI 903144A0
Authority
FI
Finland
Prior art keywords
snuvvirussystemet
zoner
modified
protease
trans
Prior art date
Application number
FI903144A
Other languages
Finnish (fi)
Inventor
Wolfgang Sommergruber
Peter Volkmann
Friederike Fessl
Ingrid Maurer-Fogy
Ernst Kuechler
Dieter Blaas
Timothy Skern
Manfred Zorn
Herbert Auer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI903144A0 publication Critical patent/FI903144A0/en
Priority to FI951852A priority Critical patent/FI951852A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1009—Picornaviridae, e.g. hepatitis A virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32711—Rhinovirus
    • C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to systems which make it possible to introduce mutations in the VP1/2A and in the complete coding region of the 2A protease, to test systems with which the "cis" and "trans" activity can be investigated, to oligonucleotides which encode the mutations, and to the oligopeptides derived therefrom and to the use thereof, furthermore oligopeptides which are cleaved by the 2A protease into trans with different efficiency, and to the use thereof.
FI903144A 1989-06-25 1990-06-21 MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET. FI903144A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI951852A FI951852A (en) 1989-06-25 1995-04-19 Process for making test systems

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3920860 1989-06-25
DE4018376 1990-06-08

Publications (1)

Publication Number Publication Date
FI903144A0 true FI903144A0 (en) 1990-06-21

Family

ID=25882343

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903144A FI903144A0 (en) 1989-06-25 1990-06-21 MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET.

Country Status (17)

Country Link
EP (2) EP0410147B1 (en)
JP (1) JPH04503608A (en)
KR (1) KR920701439A (en)
AT (1) ATE114717T1 (en)
AU (2) AU644078B2 (en)
CA (1) CA2019661A1 (en)
DE (2) DE59007818D1 (en)
DK (1) DK0410147T3 (en)
ES (1) ES2064537T3 (en)
FI (1) FI903144A0 (en)
GR (1) GR3015192T3 (en)
IE (2) IE950434L (en)
IL (2) IL94841A0 (en)
NO (1) NO902789L (en)
NZ (1) NZ234212A (en)
PT (1) PT94458B (en)
WO (1) WO1991000348A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4136443A1 (en) * 1991-11-06 1993-05-13 Boehringer Ingelheim Int EXPRESSION OF THE TIRE PROTEINASE 2A, ITS PARTIAL CLEANING AND PROVISION OF COMPETITIVE SUBSTRATES
US8318423B2 (en) 2004-07-06 2012-11-27 Focus Diagnostics, Inc. Methods and compositions for detecting rhinoviruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263903A1 (en) * 1986-10-10 1988-04-20 E.I. Du Pont De Nemours And Company Method for preparing specific inhibitors of virus-specified proteases
ES2059482T3 (en) * 1987-12-23 1994-11-16 Boehringer Ingelheim Int EXPRESSION OF HRV2 PROTEASE P2A CODED BY VIRUSES.

Also Published As

Publication number Publication date
NO902789D0 (en) 1990-06-22
DE4020211A1 (en) 1991-01-17
EP0410147B1 (en) 1994-11-30
KR920701439A (en) 1992-08-11
NZ234212A (en) 1993-03-26
AU657205B2 (en) 1995-03-02
IL112507A0 (en) 1995-05-26
NO902789L (en) 1990-12-27
DK0410147T3 (en) 1995-03-13
WO1991000348A3 (en) 2004-04-29
GR3015192T3 (en) 1995-05-31
IE902270L (en) 1990-12-25
CA2019661A1 (en) 1990-12-25
EP0410147A1 (en) 1991-01-30
IE950434L (en) 1990-12-25
PT94458A (en) 1991-02-08
DE59007818D1 (en) 1995-01-12
AU3524593A (en) 1993-05-27
IE66395B1 (en) 1995-12-27
JPH04503608A (en) 1992-07-02
IE902270A1 (en) 1991-01-16
IL94841A0 (en) 1991-04-15
EP0602687A1 (en) 1994-06-22
AU5779690A (en) 1991-01-03
ATE114717T1 (en) 1994-12-15
AU644078B2 (en) 1993-12-02
WO1991000348A1 (en) 1991-01-10
ES2064537T3 (en) 1995-02-01
PT94458B (en) 1997-02-28

Similar Documents

Publication Publication Date Title
DE60143292D1 (en) Variants of human coagulation factor VII
ATE322547T1 (en) ADENOVIRAL VECTORS FOR THE TREATMENT OF HEMOPHILIA
ATE320495T1 (en) CALCIUM-FREE SUBTILISIN MUTANTS
DE69833784D1 (en) POLYPEPTIDES WITH AMINOOPEPTIDASE ACTIVITY AND FOR THESE ENCODING NUCLEIC ACIDS
ATE399857T1 (en) COMPUTER-MEDIATED ASSEMBLY OF POLYNUCLEOTIDES ENCODING A TARGETED POLYPEPTIDE
ATE135371T1 (en) PROTEIN ASSOCIATED WITH ACUTE PANCREATITIS, AGENTS FOR DIAGNOSING ACUTE PANCREATITIS
DE68914664D1 (en) PURIFIED UBIQUITIN HYDROLASE, THESE ENCODING DNA SEQUENCES, AND THEIR USE TO OBTAIN POLYPEPTIDES.
BR9810701A (en) Trichoderma reesei protein "swollenin" and DNA coding sequences
DE69329195D1 (en) RECOMBINANT DNA MOLECULES ENCODE THE AMINOPEPTIDASE ENZYME AND THEIR APPLICATION FOR THE PRODUCTION OF VACCINES AGAINST HELMINTH INFECTIONS
DK0804558T3 (en) tripeptidyl aminopeptidase
DE3853156D1 (en) POLYESTER FABRIC FOR THE PRODUCTION OF ELECTROPHORESELS AND ELECTROPHORESEL.
TR199802376T1 (en) Oxalate Decarboxylase Coding Gen from Aspergillus Phoenices.
ATE218616T1 (en) HUMAN CIRCULATIVE CYTOKINE CC-1
FI903144A0 (en) MODIFIED VP1 / P2A ZONER I SNUVVIRUSSYSTEMET.
DE69534470T2 (en) LGMD GENERATING FOR A CALCIUM-DEPENDENT PROTEASE
SE9602822D0 (en) New receptor
ES2060134T3 (en) METALOPROTEASE TISSUE INHIBITOR (TIMP-2).
ATE412751T1 (en) HUMAN TAK1 AND DNA CODING FOR IT
EA200100314A1 (en) PEPTIDE FRAGLES OF CHOLER EXOTOXIN IN OR ENTEROXINE IN AS AN ADJUVANT VACCINE
ATE242883T1 (en) METHOD FOR DETERMINING BLOOD CLOTTING FACTORS VIII AND IX
SE9604439D0 (en) New receptor
ATE432985T1 (en) POLYPEPTIDES WITH NEUTROPHIL STIMULATING ACTIVITY
TH9496EX (en) The mutant species of substiline
RU96124779A (en) DNA ENCODING BACILUS LICHENIFORMIS PWD-1 KERATINASE
ATE279520T1 (en) VARICELLA ZOSTER VIRUS (VZV) IMMUNOREACTIVE PROTEIN VP26 AND ITS DIAGNOSTIC USE

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH